These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1752152)

  • 81. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients.
    Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q
    J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Acute effect of small dosages of somatostatin analogue SMS201-995 on gallbladder contractility in normal adults].
    Zhu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Jun; 14(3):201-5. PubMed ID: 1394739
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.
    Ewins DL; Javaid A; Coskeran PB; Shah S; Butler J; Deprez PH; Miell J; Calam J; Barrett JJ; Dawson JM
    Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A prospective examination of octreotide-induced gall-bladder changes in acromegaly.
    Eastman RC; Arakaki RF; Shawker T; Schock R; Roach P; Comi RJ; Gorden P
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):265-9. PubMed ID: 1563079
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management.
    Redfern JS; Fortuner WJ
    Am J Gastroenterol; 1995 Jul; 90(7):1042-52. PubMed ID: 7611194
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Besser GM; Wass JA
    Metabolism; 1992 Sep; 41(9 Suppl 2):22-33. PubMed ID: 1355588
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201-995).
    Hopman WP; van Liessum PA; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB; Kloppenborg PW
    Digestion; 1990; 45 Suppl 1():72-6. PubMed ID: 2185969
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Wass JA
    Digestion; 1993; 54 Suppl 1():107-20. PubMed ID: 8103009
    [No Abstract]   [Full Text] [Related]  

  • 89. Proceedings of the workshop, "Practical approaches to the diagnosis and treatment of acromegaly".
    Liuzzi A; Sobrinho LG; Besser GM
    Metabolism; 1992 Sep; 41(9 Suppl 2):87-90. PubMed ID: 1518440
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Proceedings of the discussion, "Tolerability and safety of Sandostatin".
    Wass JA; Popovic V; Chayvialle JA
    Metabolism; 1992 Sep; 41(9 Suppl 2):80-2. PubMed ID: 1518439
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly].
    Zhu XF; Shi YF; Zhang JX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):405-8, 455. PubMed ID: 1752152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.